Your browser doesn't support javascript.
loading
Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes.
Ruano, Luis; Portaccio, Emilio; Goretti, Benedetta; Niccolai, Claudia; Severo, Milton; Patti, Francesco; Cilia, Sabina; Gallo, Paolo; Grossi, Paola; Ghezzi, Angelo; Roscio, Marco; Mattioli, Flavia; Stampatori, Chiara; Trojano, Maria; Viterbo, Rosa Gemma; Amato, Maria Pia.
Afiliação
  • Ruano L; EPIUnit, Institute of Public Health, University of Porto, Porto, Portugal/Department of Clinical Epidemiology, Predictive Medicine and Public Health, University of Porto Medical School, Porto, Portugal/Entre Douro e Vouga Hospital Centre, Santa Maria da Feira, Portugal.
  • Portaccio E; University of Florence, Florence, Italia.
  • Goretti B; University of Florence, Florence, Italia.
  • Niccolai C; University of Florence, Florence, Italia.
  • Severo M; EPIUnit, Institute of Public Health, University of Porto, Porto, Portugal/Department of Clinical Epidemiology, Predictive Medicine and Public Health, University of Porto Medical School, Porto, Portugal.
  • Patti F; University of Catania, Catania, Italia.
  • Cilia S; University of Catania, Catania, Italia.
  • Gallo P; University of Padova, Padova, Italia.
  • Grossi P; University of Padova, Padova, Italia.
  • Ghezzi A; Gallarate Hospital, Gallarate, Italia.
  • Roscio M; Gallarate Hospital, Gallarate, Italia.
  • Mattioli F; Spedali Civili Brescia, Brescia, Italia.
  • Stampatori C; Spedali Civili Brescia, Brescia, Italia.
  • Trojano M; University of Bari, Bari, Italia.
  • Viterbo RG; University of Bari, Bari, Italia.
  • Amato MP; University of Florence, Florence, Italia.
Mult Scler ; 23(9): 1258-1267, 2017 Aug.
Article em En | MEDLINE | ID: mdl-27738090
ABSTRACT

BACKGROUND:

There is limited and inconsistent information on the clinical determinants of cognitive impairment (CI) in multiple sclerosis (MS).

OBJECTIVE:

The aim of this study was to compare the prevalence and profile of CI across MS disease subtypes and assess its clinical determinants.

METHODS:

Cognitive performance was assessed through the Brief Repeatable Battery and the Stroop test in consecutive patients with MS referred to six Italian centers. CI was defined as impairment in ⩾ 2 cognitive domains.

RESULTS:

A total of 1040 patients were included, 167 with clinically isolated syndrome (CIS), 759 with relapsing remitting (RR), 74 with secondary progressive (SP), and 40 with primary progressive (PP) disease course. The overall prevalence of CI was 46.3%; 34.5% in CIS, 44.5% in RR, 79.4% in SP, and 91.3% in PP. The severity of impairment and the number of involved domains were significantly higher in SP and primary progressive multiple sclerosis (PPMS) than in CIS and RR. In multivariable logistic regression analysis, the presence of CI was significantly associated with higher Expanded Disability Status Scale (EDSS) and older age.

CONCLUSION:

CI is present in all MS subtypes since the clinical onset and its frequency is increased in the progressive forms, but these differences seem to be more associated with patient age and physical disability than to disease subtype per se.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Crônica Progressiva / Esclerose Múltipla Recidivante-Remitente / Disfunção Cognitiva Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Mult Scler Assunto da revista: NEUROLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Portugal

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Crônica Progressiva / Esclerose Múltipla Recidivante-Remitente / Disfunção Cognitiva Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Mult Scler Assunto da revista: NEUROLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Portugal